Quinlan Paul T sold ORKA
September 21, 2026 · Form 4 insider transaction
Quinlan Paul T sold 601 shares of Oruka Therapeutics, Inc. at $94.44 per share, a transaction worth $56.8K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
601
Price
$94.44
Total value
$56.8K
InsiderQuinlan Paul T
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 21, 2026
Filing dateSeptember 21, 2026
Shares owned after32,662
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on May 15, 2026.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.02 to $94.98, inclusive.